PHARMACOVIGILANCE FORUM

Click here to read the full issue in your browser Follow us

Dear VIJAY PITHADIA: Your March 2015 digital issue of P&T journal is available. This issue contains: Feature articles   PHARMACOVIGILANCE FORUM Medication-Induced Hypokalemia A potassium deficiency can impair metabolic functions, and medications cause hypokalemia through a variety of mechanisms. The authors report on a 58-year-old female suffering from fatigue and weakness after a recent diagnosis of adrenal insufficiency.   A Review of 2014 Cancer Drug Approvals, With a Look at 2015 and Beyond The number of cancer medications approved by the Food and Drug Administration has risen steadily in recent years. This article provides a concise overview of drugs and indications added to the cancer armamentarium in 2014 and to date in 2015.   Employers and Drugstores Press for PBM Transparency A Labor Department Advisory Committee Has Recommended Changes Efforts are under way to convince the U.S. Department of Labor to require more transparency from pharmacy benefit managers, which divulge few details of their financial arrangements to their customers.   Bivalirudin Versus Heparin: A Fight Far From Finished? Efficacy, Safety, and Cost Remain Battlegrounds for the Treatment Of ST-Segment Elevation Myocardial Infarction A strident debate has been surging in the interventional cardiology community over the triumvirate of efficacy, safety, and cost of bivalirudin compared with heparin for anticoagulation of patients with ST-segment elevation myocardial infarction.   PIPELINE PLUS Major Depressive Disorder New Products Are Facing a Saturated Market Major depressive disorder is complex and poorly understood; myriad drugs target numerous mechanisms of action. By 2023, sales are expected to reach $7.6 billion.   Plus our regular columns: Medication Errors, Prescription: Washington, New Drugs/Drug News/New Medical Devices, Pharmaceutical Approval Update, and Drug Forecast. Click here to begin reading the current issue. Click here to subscribe to P&T journal Call for Papers P&T is accepting article submissions from its readers. We welcome a wide variety of manuscripts, including drug class reviews, disease state management reviews, pharmacoeconomic analyses, outcomes research evaluations, DUEs, P&T committee experiences, commentaries, book reviews, and letters to the editor. Please contact Sonja Sherritze, via phone (267-685-2779) or mobile 267-907-5642) or e-mail (ssherritze@medimedia.com) for more information. We hope you enjoy this issue of P&T. If you have any comments or questions about this digital format, please e-mail us atmail@ptcommunity.com. Sonja Sherritze Editor